within Pharmacolibrary.Drugs.ATC.M;

model M01CB03
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 2.3333333333333332e-05,
    adminDuration  = 600,
    adminMass      = 6 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00023999999999999998,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0011666666666666668,
    Tlag           = 600,            
    Vdp             = 0.0106,
    k12             = 2.6,
    k21             = 2.6
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01CB03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Auranofin is a gold-containing compound previously approved for the treatment of rheumatoid arthritis. It acts as a disease-modifying antirheumatic drug (DMARD), but due to availability of better-tolerated agents, its clinical use has declined. Recently, it is also under investigation for other therapeutic indications such as antibacterial and antitumor activity.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters derived from studies in adult patients with rheumatoid arthritis following oral administration.</p><h4>References</h4><ol><li><p>Delafuente, JC, &amp; Osborn, TG (1984). Review of auranofin, an oral chrysotherapeutic agent. <i>Clinical pharmacy</i> 3(2) 121–127. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6426843/&quot;>https://pubmed.ncbi.nlm.nih.gov/6426843</a></p></li><li><p>Blocka, KL, et al., &amp; Furst, DE (1986). Clinical pharmacokinetics of oral and injectable gold compounds. <i>Clinical pharmacokinetics</i> 11(2) 133–143. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198611020-00003&quot;>10.2165/00003088-198611020-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3082559/&quot;>https://pubmed.ncbi.nlm.nih.gov/3082559</a></p></li><li><p>Walz, DT, et al., &amp; Flanagan, TL (1983). Biologic actions and pharmacokinetic studies of auranofin. <i>The American journal of medicine</i> 75(6A) 90–108. DOI:<a href=&quot;https://doi.org/10.1016/0002-9343(83)90481-3&quot;>10.1016/0002-9343(83)90481-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6318557/&quot;>https://pubmed.ncbi.nlm.nih.gov/6318557</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01CB03;
